JOHNS HOPKINS UNIVERSITY
- Country
- π³π¦Namibia
- Ownership
- -
- Established
- 1876-01-01
- Employees
- 19.4K
- Market Cap
- -
- Website
- https://www.jhu.edu/
Eculizumab to Enable Renal Transplantation in Patients With History of Catastrophic Antiphospholipid Antibody Syndrome
- Conditions
- Antiphospholipid Antibody SyndromeEnd Stage Renal Disease
- Interventions
- First Posted Date
- 2009-12-10
- Last Posted Date
- 2020-10-26
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 1
- Registration Number
- NCT01029587
- Locations
- πΊπΈ
Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
Safety and Immunologic Effect of Low Dose Versus High Dose Vitamin D3 in Multiple Sclerosis
- First Posted Date
- 2009-12-03
- Last Posted Date
- 2013-02-06
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 40
- Registration Number
- NCT01024777
- Locations
- πΊπΈ
Johns Hopkins University, Baltimore, Maryland, United States
Developing New Treatments for Tourette Syndrome: Therapeutic Trials With Modulators of Glutamatergic Neurotransmission
- First Posted Date
- 2009-11-23
- Last Posted Date
- 2018-01-30
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 39
- Registration Number
- NCT01018056
- Locations
- πΊπΈ
Johns Hopkins University, Baltimore, Maryland, United States
Safety and Tolerability of the Ketogenic Diet in Amyotrophic Lateral Sclerosis (ALS)
- Conditions
- Amyotrophic Lateral Sclerosis
- Interventions
- Dietary Supplement: KetoCal
- First Posted Date
- 2009-11-19
- Last Posted Date
- 2015-04-01
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 1
- Registration Number
- NCT01016522
- Locations
- πΊπΈ
Johns Hopkins ALS Clinic, Baltimore, Maryland, United States
Compare the Effects of Fluticasone Furoate Nasal Spray vs Placebo in Patients With Nasal Polypoid Disease
- Conditions
- Patients With Nasal Polyps
- Interventions
- Other: placebo
- First Posted Date
- 2009-11-16
- Last Posted Date
- 2017-09-13
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 7
- Registration Number
- NCT01013701
Doxycycline Outcomes in Lupus Erythematosus
- First Posted Date
- 2009-11-16
- Last Posted Date
- 2012-03-30
- Lead Sponsor
- Johns Hopkins University
- Registration Number
- NCT01014260
- Locations
- πΊπΈ
Johns Hopkins University SOM. 1830 East Monument St, Ste 7500, Baltimore, Maryland, United States
Building Adherence to Live With And Navigate my Cystic Fibrosis (CF) Experience
- Conditions
- Cystic Fibrosis
- Interventions
- Other: Cystic Fibrosis EducationBehavioral: Motivational Interviewing
- First Posted Date
- 2009-11-16
- Last Posted Date
- 2015-03-31
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 128
- Registration Number
- NCT01013896
- Locations
- πΊπΈ
Johns Hopkins, Baltimore, Maryland, United States
Muscle Derived Cell Therapy for Bladder Exstrophy Epispadias Induced Incontinence
- First Posted Date
- 2009-11-11
- Last Posted Date
- 2020-01-28
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 2
- Registration Number
- NCT01011777
- Locations
- πΊπΈ
Brady Urological Institute. Johns Hopkins University, Baltimore, Maryland, United States
The Effects of Omalizumab (Anti-IgE) on the Late-phase Response to Nasal Allergen Challenge
- First Posted Date
- 2009-10-28
- Last Posted Date
- 2014-04-07
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 19
- Registration Number
- NCT01003301
- Locations
- πΊπΈ
Johns Hopkins Asthma and Allergy Center, Baltimore, Maryland, United States
Human Psychopharmacology of Salvinorin A
- First Posted Date
- 2009-10-16
- Last Posted Date
- 2014-03-24
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 14
- Registration Number
- NCT00996411
- Locations
- πΊπΈ
Behavioral Pharmacology Research Unit, Baltimore, Maryland, United States
πΊπΈBehavioral Pharmacology Research Unit, Johnson Hopkins Univ. School of Med., Baltimore, Maryland, United States